The population impact of HPV/cytology cervical cotesting at 3-year intervals: reduced cervical cancer risk and decreased yield of precancer per screen

BACKGROUND: Cervical screening aims to detect and treat precancer to prevent cervical cancer mortality and morbidity, while minimizing overtreatment of benign human papillomavirus (HPV) infections and related minor abnormalities. HPV/cytology cotesting at extended 5-year intervals is now a recommend...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Silver, Michelle I., Schiffman, Mark, Fetterman, Barbara, Poitras, Nancy, Gage, Julia C., Wentzensen, Nicolas, Lorey, Thomas, Kinney, Walter, Castle, Philip E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5115944/
https://ncbi.nlm.nih.gov/pubmed/27657992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30277
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados